Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (531-540 of 818) with videos related to

Pageof 82
Sort By:
Diagnostic Microbiology and Infectious Disease|August 1, 1993
The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistanceD J Hoban, R N Jones, L J Harrell, et al.
Diagnostic Microbiology and Infectious Disease|August 25, 1999
Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe)B A Odland, R N Jones, J Verhoef, et al.
Journal of Clinical Microbiology|January 5, 2000
Development and application of a PCR-based method including an internal control for diagnosis of congenital cytomegalovirus infectionR N Jones, M L Neale, B Beattie, et al.
Journal of Clinical Microbiology|November 29, 2001
Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida speciesM A Pfaller, S A Messer, K Mills, et al.
Journal of Clinical Microbiology|September 28, 2001
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococciT Yamazumi, I Furuta, D J Diekema, et al.
Inhaled Particles|September 1, 1975
Differences in lung effects resulting from chrysotile and crocidolite exposureH Weill, C E Rossiter, C Waggenspack, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 1998
Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study GroupG V Doern, R N Jones, M A Pfaller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2004
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance ProgramM Castanheira, A C Gales, R E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|October 26, 1999
Colony morphology of Candida spp. as a guide to species identificationB Buschelman, R N Jones, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)J R DiPersio, R N Jones, T Barrett, et al.
Pageof 82

Showing results (531-540 of 818) with videos related to

Sort By:
Pageof 82
Diagnostic Microbiology and Infectious Disease|August 1, 1993
The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistanceD J Hoban, R N Jones, L J Harrell, et al.
Diagnostic Microbiology and Infectious Disease|August 25, 1999
Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe)B A Odland, R N Jones, J Verhoef, et al.
Journal of Clinical Microbiology|January 5, 2000
Development and application of a PCR-based method including an internal control for diagnosis of congenital cytomegalovirus infectionR N Jones, M L Neale, B Beattie, et al.
Journal of Clinical Microbiology|November 29, 2001
Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida speciesM A Pfaller, S A Messer, K Mills, et al.
Journal of Clinical Microbiology|September 28, 2001
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococciT Yamazumi, I Furuta, D J Diekema, et al.
Inhaled Particles|September 1, 1975
Differences in lung effects resulting from chrysotile and crocidolite exposureH Weill, C E Rossiter, C Waggenspack, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 1998
Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study GroupG V Doern, R N Jones, M A Pfaller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2004
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance ProgramM Castanheira, A C Gales, R E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|October 26, 1999
Colony morphology of Candida spp. as a guide to species identificationB Buschelman, R N Jones, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)J R DiPersio, R N Jones, T Barrett, et al.
Pageof 82